MedPath

ZILBRYSQ 32,4 MG, SOLUCION INYECTABLE EN JERINGA PRECARGADA

ZILBRYSQ 32,4 MG, SOLUCION INYECTABLE EN JERINGA PRECARGADA

Commercialized
Register Number

1231764005

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Dec 22, 2023

Dosage Form

SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1231764005
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

ZILUCOPLANActive
Quantity: 32,40 mg
Name: ZILUCOPLAN

ATC CLASSIFICATION (3)

L04A
L04AJ
L04AJ06

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.